Verdasan Flydende middel Dänemark - Dänisch - SEGES Landbrug & Fødevarer

verdasan flydende middel

zeneca agro - eptc - flydende middel - 720 g/l eptc

Ambush Flydende middel Dänemark - Dänisch - SEGES Landbrug & Fødevarer

ambush flydende middel

zeneca agro - permethrin - flydende middel - 250 g/l permethrin

Karate 10 CS Flydende middel Dänemark - Dänisch - SEGES Landbrug & Fødevarer

karate 10 cs flydende middel

zeneca agro - lambda-cyhalothrin - flydende middel - 100 g/l lambda-cyhalothrin

Daconil 500 F Suspensionskoncentrat Dänemark - Dänisch - SEGES Landbrug & Fødevarer

daconil 500 f suspensionskoncentrat

zeneca agro - chlorothalonil - suspensionskoncentrat - 500 g/l chlorothalonil

Fluenz Europäische Union - Dänisch - EMA (European Medicines Agency)

fluenz

medimmune llc - reassortant influenza-virus (levende, svækkede) af følgende stammer:a/california/7/2009 (h1n1)pdm09 lignende stamme, a/victoria/361/2011 (h3n2) som stamme, b/massachusetts/2/2012 lignende stamme - influenza, human; immunization - vacciner - prophylax af influenza hos individer 24 måneder til under 18 år. brug af fluenz bør være baseret på officielle anbefalinger.

Atacand Zid 16 mg/12,5 mg 16+12,5 mg tabletter Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

atacand zid 16 mg/12,5 mg 16+12,5 mg tabletter

cheplapharm arzneimittel gmbh - candesartancilexetil, hydrochlorthiazid - tabletter - 16+12,5 mg

Atacand Zid 32 mg/12,5 mg 32+12,5 mg tabletter Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

atacand zid 32 mg/12,5 mg 32+12,5 mg tabletter

cheplapharm arzneimittel gmbh - candesartancilexetil, hydrochlorthiazid - tabletter - 32+12,5 mg

Atacand Zid 32mg /25 mg 32+25 mg tabletter Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

atacand zid 32mg /25 mg 32+25 mg tabletter

cheplapharm arzneimittel gmbh - candesartancilexetil, hydrochlorthiazid - tabletter - 32+25 mg

Imfinzi Europäische Union - Dänisch - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - carcinom, ikke-småcellet lunge - antineoplastiske midler - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Symbicort 2,25+80 mikrog/dosis inhalationsspray, suspension Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

symbicort 2,25+80 mikrog/dosis inhalationsspray, suspension

astrazeneca a/s - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 2,25+80 mikrog/dosis